These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 14753095)
1. Mifepristone for medical abortion. Exploring a new option for nurse practitioners. Taylor D; Hwang AC AWHONN Lifelines; 2003 Dec-2004 Jan; 7(6):524-9. PubMed ID: 14753095 [No Abstract] [Full Text] [Related]
2. Professional considerations for providing mifepristone-induced abortion. Fielding SL; Lee SS; Schaff EA Nurse Pract; 2001 Nov; 26(11):44-54. PubMed ID: 11759615 [TBL] [Abstract][Full Text] [Related]
3. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Hausknecht R Contraception; 2003 Jun; 67(6):463-5. PubMed ID: 12814815 [TBL] [Abstract][Full Text] [Related]
4. Medical management of first-trimester abortion. Contraception; 2014 Mar; 89(3):148-61. PubMed ID: 24795934 [No Abstract] [Full Text] [Related]
5. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy. Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190 [TBL] [Abstract][Full Text] [Related]
6. First trimester abortion with mifepristone and vaginal misoprostol. Knudsen UB Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463 [TBL] [Abstract][Full Text] [Related]
7. Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data. Cleland K; Smith N Contraception; 2015 Sep; 92(3):179-81. PubMed ID: 26093188 [No Abstract] [Full Text] [Related]
9. Use of mifepristone for medical abortion in Australia, 2006-2009. de Costa CM Med J Aust; 2011 Feb; 194(4):206-7. PubMed ID: 21401466 [No Abstract] [Full Text] [Related]
10. Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion. Sparrow M; Shand C; Macdonald J Contraception; 2006 Oct; 74(4):352-3; author reply 353-4. PubMed ID: 16982242 [No Abstract] [Full Text] [Related]
11. Medical abortion for adolescents. Grimes DA; Raymond EG BMJ; 2011 Apr; 342():d2185. PubMed ID: 21508043 [No Abstract] [Full Text] [Related]
12. Early abortion. Update and implications for midwifery practice. Narrigan D J Nurse Midwifery; 1998; 43(6):492-501. PubMed ID: 9871382 [TBL] [Abstract][Full Text] [Related]
13. Mifepristone: less obvious adverse effects. Rudd G Ann Pharmacother; 2001 Mar; 35(3):381-2. PubMed ID: 11261540 [No Abstract] [Full Text] [Related]
14. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079 [TBL] [Abstract][Full Text] [Related]
15. [Practical guidance for termination of pregnancy at 8 to 16 weeks gestation with mifepristone and misoprostol]. Chinese Society of Family Planning, Chinese Medical Association Zhonghua Fu Chan Ke Za Zhi; 2015 May; 50(5):321-2. PubMed ID: 26311448 [No Abstract] [Full Text] [Related]
16. Efficacy of simultaneous use of mifepristone and misoprostol for early abortion. Li YT; Chen TH; Kuo TC Int J Gynaecol Obstet; 2008 Jun; 101(3):301. PubMed ID: 18289538 [No Abstract] [Full Text] [Related]
17. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation. Fox MC; Creinin MD; Harwood B Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616 [TBL] [Abstract][Full Text] [Related]